{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:49Z","timestamp":1760057269389,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ajem.2023.11.016","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:06:47Z","timestamp":1700345207000},"page":"231-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nitrous oxide myeloneuropathy as the differential diagnosis of Guillain-Barre syndrome"],"prefix":"10.1016","volume":"76","author":[{"given":"Oscar M.P.","family":"Jolobe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2023.11.016_bb0005","doi-asserted-by":"crossref","unstructured":"Madden J., Spadaro A., Koyfman A., Long B, High risk and low prevalence diseases: Gillain-Barre syndrome, Am J Emerg Med Article in press,https:\/\/doi.org\/10.1016\/j.ajem.2023.10.036","DOI":"10.1016\/j.ajem.2023.10.036"},{"key":"10.1016\/j.ajem.2023.11.016_bb0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s12640-021-00352-y","article-title":"Recreational nitrous oxide abuse: prevalence, neurotoxicity, and treatment","volume":"39","author":"Xiang","year":"2021","journal-title":"Neurotox Res"},{"key":"10.1016\/j.ajem.2023.11.016_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jns.12503","article-title":"Acute nitrous oxide-induced neuropathy mimicking Guillain-Barre syndrome","volume":"27","author":"Qin","year":"2022","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ajem.2023.11.016_bb0020","doi-asserted-by":"crossref","DOI":"10.2147\/NDT.S270179","article-title":"Li M et al, reversible neuropsychiatric disturbances caused by nitrous oxide toxicity: clinical imaging and electrophysiological profiles of 21 patients with 6-12 months follow up","author":"Zheng","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.ajem.2023.11.016_bb0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1552-6569.2009.00388.x","article-title":"Pseudo-Guillain-Barre syndrome due to \u201cwhippet\u201d-induced myeloneuropathy","volume":"20","author":"Tatum","year":"2010","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.ajem.2023.11.016_bb0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00415-018-8801-3","article-title":"No laughing matter:subacute degeneration of the spinal cord due to nitrous oxide inhalation","volume":"265","author":"Keddie","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.ajem.2023.11.016_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1054\/jocn.1998.0149","article-title":"Nitrous oxide myelopathy in an abuser of whipped cream bulbs","volume":"7","author":"Butzkuevan","year":"2000","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ajem.2023.11.016_bb0040","first-page":"129","article-title":"Subacute combined degeneration caused by nitrous oxide intoxication: case reports","volume":"20","author":"Lin","year":"2011","journal-title":"Acta Neurol Taiwanica"},{"key":"10.1016\/j.ajem.2023.11.016_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s40495-023-00334-y","article-title":"Guillain Barre syndrome as a complication of infections including COVID-19: a review","author":"Kurup","year":"2023","journal-title":"Curr Pharmacol Reports"},{"key":"10.1016\/j.ajem.2023.11.016_bb0050","article-title":"Nitrous oxide in France: evolution of complications reported o the French monitoring system in the context of information from health authorities and regulatory measures","author":"Guerlois","year":"2023","journal-title":"Int J Drug Policy"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723006290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723006290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:09:15Z","timestamp":1760026155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675723006290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":10,"alternative-id":["S0735675723006290"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2023.11.016","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrous oxide myeloneuropathy as the differential diagnosis of Guillain-Barre syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2023.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}